Isoquinolinone derivatives as NK3 antagonists

Details for Australian Patent Application No. 2009291309 (hide)

Owner H. Lundbeck A/S

Inventors Khanzhin, Nikolay; Juhl, Karsten; Nielsen, Soren Moller; Simonsen, Klaus Baek

Agent Spruson & Ferguson

Pub. Number AU-A-2009291309

PCT Pub. Number WO2010/028655

Priority PA200900010 06.01.09 DK; PA200801290 15.09.08 DK

Filing date 11 September 2009

Wipo publication date 18 March 2010

International Classifications

C07D 217/26 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 407/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/028655 Priority application(s): WO2010/028655

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009291312-YKL-40 as a marker for gastrointestinal cancers

2009291291-System for producing synthesis gas